Frenking, J., Zhou, X., Wagner, V., Hielscher, T., Kauer, J., Mai, E. K., . . . Raab, M. (2024). EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma. Journal for ImmunoTherapy of Cancer, 12(10), . https://doi.org/10.1136/jitc-2024-009220
Chicago-Zitierstil (17. Ausg.)Frenking, Jan, et al. "EASIX-guided Risk Stratification for Complications and Outcome After CAR T-cell Therapy with Ide-cel in Relapsed/refractory Multiple Myeloma." Journal for ImmunoTherapy of Cancer 12, no. 10 (2024). https://doi.org/10.1136/jitc-2024-009220.
MLA-Zitierstil (9. Ausg.)Frenking, Jan, et al. "EASIX-guided Risk Stratification for Complications and Outcome After CAR T-cell Therapy with Ide-cel in Relapsed/refractory Multiple Myeloma." Journal for ImmunoTherapy of Cancer, vol. 12, no. 10, 2024, https://doi.org/10.1136/jitc-2024-009220.